Metagenomi, Inc. Common Stock (NASDAQ:MGX) · earnings preview
Quarter
Q3
EPS estimate to actual
-$0.64
Revenue estimate to actual
$2.1M
At a glance
Key takeaways
01Metagenomi, Inc. (MGX) will report Q3 2026 earnings on November 10, 2026 after market close.
02Analysts expect Q3 earnings per share of $-0.64, worsening from $0.00 last year, while revenue is projected at $2.1M.
03The stock trades at $0.71 with a market capitalization of $65.7M as of the article date.
04Recent earnings have consistently missed estimates: Q2 missed by 35.2%, Q1 by 8.9%, and Q4 by 3.4%.
Earnings Results
Metagenomi, Inc. Common Stock (NASDAQ:MGX) is scheduled to report its Q3 earnings results on November 10, 2026 after market close.
Analysts expect the Healthcare company to report earnings per share of $-0.64, below the $0.00 reported in the same quarter last year. Revenue is expected to come in at $2.1M, up from a year ago.
Company Overview
The stock currently trades at $0.71 with a market capitalization of $65.7M.
Ahead of Metagenomi, Inc. Common Stock's earnings report, investors are watching several key metrics beyond the headline EPS number. Revenue growth, margin trends, and forward guidance will likely carry more weight than a single quarter's earnings figure in determining the stock's direction after the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Metagenomi, Inc. Common Stock should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.